{"groups":[{"description":"Pemetrexed 500 mg/m2 IV Day 1 every 21 days for 6 cycles Cisplatin 75 mg/m2 IV Day 1 every 21 days for 6 cycles\n\nCisplatin\n\nPemetrexed","id":"FG000","title":"Arm A - Cisplatin/Pemetrexed (Phase II)"},{"description":"Pembrolizumab 200 mg\\* IV Day 1 over 30 min every 21 days for a total of 2 years Pemetrexed 500 mg/m2 IV Day 1 every 21 days for 6 cycles Cisplatin 75 mg/m2 IV Day 1 every 21 days for 6 cycles\n\nCisplatin\n\nPemetrexed\n\nPembrolizumab","id":"FG001","title":"Arm B - Cisplatin/Pemetrexed/Pembrolizumab (Phase II)"},{"description":"Pembrolizumab 200 mg\\* IV 30 min Day 1 every 21 days for a total of 2 years\n\nPembrolizumab","id":"FG002","title":"Arm C - Pembrolizumab (Phase II Only)"},{"description":"Pemetrexed 500 mg/m2 IV Day 1 every 21 days for 6 cycles Cisplatin 75 mg/m2 IV Day 1 every 21 days for 6 cycles\n\nCisplatin\n\nPemetrexed","id":"FG003","title":"Arm A - Cisplatin/Pemetrexed (Phase III)"},{"description":"Pembrolizumab 200 mg\\* IV Day 1 over 30 min every 21 days for a total of 2 years Pemetrexed 500 mg/m2 IV Day 1 every 21 days for 6 cycles Cisplatin 75 mg/m2 IV Day 1 every 21 days for 6 cycles Cisplatin Pemetrexed Pembrolizumab","id":"FG004","title":"Arm B - Cisplatin/Pemetrexed/Pembrolizumab (Phase III)"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"21"},{"groupId":"FG001","numSubjects":"19"},{"groupId":"FG002","numSubjects":"40"},{"groupId":"FG003","numSubjects":"218"},{"groupId":"FG004","numSubjects":"222"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"21"},{"groupId":"FG001","numSubjects":"19"},{"groupId":"FG002","numSubjects":"40"},{"groupId":"FG003","numSubjects":"218"},{"groupId":"FG004","numSubjects":"222"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}